| Strategies |
| • Target immune checkpoints to prevent immune suppression |
| • Promote tumor cell phagocytosis and antigen presentation by engaging macrophages |
| • Improve malignant cell engagement using CARs |
| • Activate T cells and NK cells using bispecific antibodies |
| Strategies |
| • Target immune checkpoints to prevent immune suppression |
| • Promote tumor cell phagocytosis and antigen presentation by engaging macrophages |
| • Improve malignant cell engagement using CARs |
| • Activate T cells and NK cells using bispecific antibodies |